Balsa A., Díaz del Campo Fontecha P., Silva Fernández L., Valencia Martín J., Nistal Martínez V., León Vázquez F., Hernández Hernández M.V., Corominas H., Cáliz Cáliz R., Aguado García J.M., Candelas Rodríguez G., Ibargoyen Roteta N., Martí Carbajal A., Plana Farras M.N., Puñal Riobóo J., Park H.S., Triñanes Pego Y., Villaverde García V.. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reuma.2023.07.001. PMID:. IF:(Q/D).

Sainz, L, Riera, P, Moya, P, Bernal, S, Casademont, J, Diaz-Torne, C, Millan, AM, Park, HS, Lasa, A, Corominas, H. Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2023; 25(1)DOI:10.1186/s13075-023-03209-1. PMID:38001504. IF:4.400(Q1/3D).

Valero-Martínez, C, Urgelles, JF, Sallés, M, Joven-Ibáñez, BE, de Juanes, A, Ramírez, J, Juanola, X, Almodóvar, R, Laiz, A, Moreno, M, Pujol, M, Beltrán, E, Pinto-Tasende, JA, Crespí, L, Sala-Icardo, L, Castañeda, S, García-Vicuña, R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5.700(Q1/3D).

Osuna-Gomez, R, Castellvi, I, Mulet, M, Ortiz, MA, Brough, DE, Sabzevari, H, Semnani, RT, Vidal, S. Impaired Regulation by IL-35 in Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310567. PMID:37445745. IF:4.900(Q1/3D).